Loading organizations...
§ Private Profile · Potsdam, Brandenburg, Germany
Healthcare technology company developing tele-medical products for diabetes management, automating insulin tracking and remote monitoring.
Founded in 2008, Emperra is a healthcare technology company based in Potsdam, Germany, developing telemedical hardware and software systems for comprehensive diabetes management. Led by CEO Christian Krey, the company provides the proprietary ESYSTA platform, which automates insulin and blood sugar tracking using encrypted data transfer to cloud infrastructure for AI processing and remote monitoring. The organization generates revenue by selling its medical devices to healthcare providers and securing selective contracts with insurers like AOK-NO to demonstrate measurable health economic benefits. Backed by venture capital investors including IBB Ventures and Peppermint Venture Partners, the company has secured 6,560,000 dollars in total funding, including a Series B round, to scale its public health solutions. Emperra currently holds four patents, including a recently granted patent for an insulin cartridge assembly administration system, further solidifying its certified telediabetology ecosystem.
Emperra has raised $3.1M across 1 funding round.
Emperra has raised $3.1M in total across 1 funding round.
Emperra has raised $3.1M in total across 1 funding round.
Emperra's investors include Investitionsbank des Landes Brandenburg, Peppermint Venture Partners, Robert Bosch Venture Capital.
Emperra has raised $3.1M across 1 funding round. Most recently, it raised $3.1M Series B in January 2016.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 5, 2016 | $3.1M Series B | — | Investitionsbank DES Landes Brandenburg, Peppermint Venture Partners, Robert Bosch Venture Capital | Announced |